Milton C Weinstein

发表

Identifying key parameters in cost-effectiveness analysis using value of information: a comparison of methods.

Bas Groot Koerkamp, M G Myriam Hunink, Theo Stijnen, 2006, Health economics.

Model Parameter Estimation and Uncertainty: a Report of the Ispor-smdm Modeling Good Research Practices Task Force-6 Background to the Task Forcemodel-parameter-estimation-and- Uncertainty-analysis.asp). a Summary of These Articles Was Pre- Sented at a Plenary Session at the Ispor 16th Annual Intern

Jonathan Karnon, Mark J Sculpher, Milton C Weinstein, 2022 .

A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].

Milton C Weinstein, Scott D Ramsey, Louis P Garrison, 2018, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis

Bas Groot Koerkamp, Theo Stijnen, Milton C Weinstein, 2007, Medical decision making : an international journal of the Society for Medical Decision Making.

Model Parameter Estimation and Uncertainty Analysis

Jonathan Karnon, Mark J Sculpher, Milton C Weinstein, 2012, Medical decision making : an international journal of the Society for Medical Decision Making.

A novel method to estimate the indirect community benefit of HIV interventions using a microsimulation model of HIV disease

Milton C Weinstein, Pooyan Kazemian, Kenneth A Freedberg, 2020, J. Biomed. Informatics.

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

Milton C Weinstein, Bryan R Luce, Magnus Johannesson, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Chapter 9: The MGH‐HMS Lung Cancer Policy Model: Tobacco Control Versus Screening

G Scott Gazelle, Milton C Weinstein, Lauren E Cipriano, 2012, Risk analysis : an official publication of the Society for Risk Analysis.

Heart failure disease management programs: a cost-effectiveness analysis.

Milton C Weinstein, M. Weinstein, P. Heidenreich, 2008, American heart journal.

When to start antiretroviral therapy in resource-limited settings.

Milton C Weinstein, A David Paltiel, Elena Losina, 2009, Annals of internal medicine.

Cost effectiveness of a gene expression score and myocardial perfusion imaging for diagnosis of coronary artery disease.

Milton C Weinstein, Pamela S Douglas, Kevin J. Leahy, 2012, American heart journal.

Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'Ivoire.

Milton C Weinstein, Elena Losina, Sue J Goldie, 2006, The New England journal of medicine.

Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.

Joshua T. Cohen, Milton C Weinstein, Joshua T Cohen, 2014, The New England journal of medicine.

Does preventive care save money? Health economics and the presidential candidates.

Joshua T. Cohen, Milton C Weinstein, Joshua T Cohen, 2008, The New England journal of medicine.

Adopting helical CT screening for lung cancer

G Scott Gazelle, Milton C Weinstein, Lauren E Cipriano, 2008, Cancer.

The Anticipated Clinical and Economic Effects of 909090 in South Africa

Milton C Weinstein, A David Paltiel, Stephen C Resch, 2016, Annals of Internal Medicine.

Patient and community preferences for treatments and health states in multiple sclerosis

Amit Bar-Or, Milton C Weinstein, Karen M Kuntz, 2003, Multiple sclerosis.

Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Milton C Weinstein, A David Paltiel, Elena Losina, 2005, The New England journal of medicine.

Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency.

Milton C Weinstein, Martina Penazzato, Taige Hou, 2016, The Journal of infectious diseases.

Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.

Milton C Weinstein, Ankur Pandya, Sylvia Cho, 2015, JAMA.

Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis.

Amit Bar-Or, Milton C Weinstein, Karen M Kuntz, 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Calibrating longitudinal models to cross-sectional data: the effect of temporal changes in health practices.

Milton C Weinstein, Rowan Iskandar, Ankur Pandya, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis

Milton C Weinstein, M. Weinstein, L. Opie, 2006, The Lancet.

The global cost of nonoptimal blood pressure

Milton C Weinstein, Asaf Bitton, M. Weinstein, 2009, Journal of hypertension.

Cost-effectiveness analysis of predischarge monitoring for apnea of prematurity.

Milton C Weinstein, Bernie J O'Brien, B. O'brien, 2003, Pediatrics.

Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine.

Milton C Weinstein, Sue J Goldie, Thomas C Wright, 2004, Journal of the National Cancer Institute.

Should physicians be gatekeepers of medical resources?

Milton C Weinstein, M. Weinstein, F. Verdú-Pascual, 2001, Journal of medical ethics.

Quantitative Risk Stratification in Markov Chains with Limiting Conditional Distributions

Milton C Weinstein, M. Weinstein, P. Pollett, 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

Comparative effectiveness and health care spending--implications for reform.

Milton C Weinstein, M. Weinstein, Jonathan A Skinner, 2010, The New England journal of medicine.

Comparative effectiveness: asking the right questions, choosing the right method.

Milton C Weinstein, Marc L Berger, M. Weinstein, 2005, Health affairs.

Clinical outcomes and cost-effectiveness of coronary computed tomography angiography in the evaluation of patients with chest pain.

Fabian Bamberg, Udo Hoffmann, G Scott Gazelle, 2009, Journal of the American College of Cardiology.

International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework.

Karl Claxton, Milton C Weinstein, Maarten J. IJzerman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Packaging Health Services When Resources Are Limited: The Example of a Cervical Cancer Screening Visit

Milton C Weinstein, Sue J Goldie, Joshua A Salomon, 2006, PLoS medicine.

Cost-Effectiveness of Hepatic Metastasectomy in Patients With Metastatic Colorectal Carcinoma: A State-Transition Monte Carlo Decision Analysis

G Scott Gazelle, Milton C Weinstein, Karen M Kuntz, 2003, Annals of surgery.

Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity

Milton C Weinstein, Shahin Lockman, Rochelle P Walensky, 2008, AIDS.

Cost-effectiveness implications of the timing of antiretroviral therapy in HIV-infected adults.

Milton C Weinstein, Elena Losina, Sue J Goldie, 2002, Archives of internal medicine.

Estimation of Mortality Rates for Disease Simulation Models Using Bayesian Evidence Synthesis

G Scott Gazelle, Milton C Weinstein, Alan M Zaslavsky, 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?

Milton C Weinstein, A David Paltiel, M. Weinstein, 2020, The New England journal of medicine.

Comparison of Health State Utilities Using Community and Patient Preference Weights Derived from a Survey of Patients with HIV/AIDS

Milton C Weinstein, John Brazier, Elena Losina, 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

Cost-Effectiveness of an Intervention to Improve Adherence to Antiretroviral Therapy in HIV-Infected Patients

Milton C Weinstein, A David Paltiel, Elena Losina, 2006, Journal of acquired immune deficiency syndromes.

The Lifetime Cost of Current Human Immunodeficiency Virus Care in the United States

Milton C Weinstein, Elena Losina, Bruce R Schackman, 2006, Medical care.

Empirically calibrated model of hepatitis C virus infection in the United States.

Milton C Weinstein, James K Hammitt, Sue J Goldie, 2002, American journal of epidemiology.

The survival benefits of AIDS treatment in the United States.

Milton C Weinstein, Lauren M. Mercincavage, A David Paltiel, 2006, The Journal of infectious diseases.

Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis

Milton C Weinstein, Joshua A Salomon, Stephen C Resch, 2006, PLoS medicine.

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection.

Milton C Weinstein, A David Paltiel, Elena Losina, 2003, The American journal of medicine.

The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States

Milton C Weinstein, A David Paltiel, Anne M Neilan, 2017, The Journal of infectious diseases.

Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the US

Milton C Weinstein, Taige Hou, A David Paltiel, 2015, HIV clinical trials.